Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells - PubMed (original) (raw)
Affiliations
- PMID: 12748308
Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells
A Douglas Laird et al. Mol Cancer Ther. 2003 May.
Abstract
The Src family kinases (SFKs) Src and Yes are believed to play critical roles in tumor growth, angiogenesis, invasion, and dissemination. Using a panel of highly selective and structurally diverse Src inhibitors, we found that phosphorylation of signal transducer and activator of transcription 3 [STAT3 (Y705)] and focal adhesion kinase [FAK (Y861)] was SFK dependent in cultured human colon, breast, lung, and ovarian tumor cells. These findings were reproduced in vivo in target modulation studies using tumors derived from fibroblasts overexpressing activated Src. Additionally, treatment of mice with multiple Src inhibitors resulted in inhibition of phosphorylation of FAK (Y861) and of a putative Src autophosphorylation epitope (Y419) in HT-29 human colon tumor xenografts. Next we pharmacologically examined the requirement for SFKs in asynchronous proliferation of human tumor cells. At concentrations sufficient to selectively inhibit Src, structurally diverse Src inhibitors inhibited growth of cultured human colon, breast, and lung cells on plastic under low serum conditions. In addition, these compounds inhibited anchorage-independent growth of HT-29 human colon tumor cells in soft agar. The role of SFK activity in vascular endothelial growth factor signaling was also evaluated. Inhibition of SFK signaling using structurally distinct Src inhibitors resulted in complete inhibition of vascular endothelial growth factor-dependent vascular permeability in vivo. These data demonstrate that STAT3 (Y705) and FAK (Y861) phosphoepitopes are SFK-dependent in tumor cells and reveal a requirement for SFK function in tumor cell proliferation and vascular permeability.
Similar articles
- Src mediates stimulation by vascular endothelial growth factor of the phosphorylation of focal adhesion kinase at tyrosine 861, and migration and anti-apoptosis in endothelial cells.
Abu-Ghazaleh R, Kabir J, Jia H, Lobo M, Zachary I. Abu-Ghazaleh R, et al. Biochem J. 2001 Nov 15;360(Pt 1):255-64. doi: 10.1042/0264-6021:3600255. Biochem J. 2001. PMID: 11696015 Free PMC article. - Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R. Garcia R, et al. Oncogene. 2001 May 3;20(20):2499-513. doi: 10.1038/sj.onc.1204349. Oncogene. 2001. PMID: 11420660 - The FRK/RAK-SHB signaling cascade: a versatile signal-transduction pathway that regulates cell survival, differentiation and proliferation.
Annerén C, Lindholm CK, Kriz V, Welsh M. Annerén C, et al. Curr Mol Med. 2003 Jun;3(4):313-24. doi: 10.2174/1566524033479744. Curr Mol Med. 2003. PMID: 12776987 Review. - Src kinases as therapeutic targets for cancer.
Kim LC, Song L, Haura EB. Kim LC, et al. Nat Rev Clin Oncol. 2009 Oct;6(10):587-95. doi: 10.1038/nrclinonc.2009.129. Nat Rev Clin Oncol. 2009. PMID: 19787002 Review.
Cited by
- Role of Src in Vascular Hyperpermeability Induced by Advanced Glycation End Products.
Zhang W, Xu Q, Wu J, Zhou X, Weng J, Xu J, Wang W, Huang Q, Guo X. Zhang W, et al. Sci Rep. 2015 Sep 18;5:14090. doi: 10.1038/srep14090. Sci Rep. 2015. PMID: 26381822 Free PMC article. - SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function.
Chichger H, Braza J, Duong H, Harrington EO. Chichger H, et al. Am J Respir Cell Mol Biol. 2015 Jun;52(6):695-707. doi: 10.1165/rcmb.2013-0489OC. Am J Respir Cell Mol Biol. 2015. PMID: 25317600 Free PMC article. - Caspase-3 promotes oncogene-induced malignant transformation via EndoG-dependent Src-STAT3 phosphorylation.
Zhu C, Fan F, Li CY, Xiong Y, Liu X. Zhu C, et al. Cell Death Dis. 2024 Jul 9;15(7):486. doi: 10.1038/s41419-024-06884-3. Cell Death Dis. 2024. PMID: 38977663 Free PMC article. - Targeting microRNAs with thymoquinone: a new approach for cancer therapy.
Homayoonfal M, Asemi Z, Yousefi B. Homayoonfal M, et al. Cell Mol Biol Lett. 2021 Oct 9;26(1):43. doi: 10.1186/s11658-021-00286-5. Cell Mol Biol Lett. 2021. PMID: 34627167 Free PMC article. Review. - The role of Src in solid tumors.
Wheeler DL, Iida M, Dunn EF. Wheeler DL, et al. Oncologist. 2009 Jul;14(7):667-78. doi: 10.1634/theoncologist.2009-0009. Epub 2009 Jul 6. Oncologist. 2009. PMID: 19581523 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous